(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-MESOTELINA E IMUNOCONJUGADOS DOS MESMOS

ArquivadaInvention PatentPCT · US2020038365

Application data

Number

112021025699

Type

Invention Patent

Filing

06/18/2020

Publication

03/03/2022

PCT

US2020038365

Progress at the INPI

  1. Filing06/18/20
  2. Publication03/03/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 06/18/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/26/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SILVERBACK THERAPEUTICS, INC.

US

Inventors

B. S. (pessoa física)

US

P. B. (pessoa física)

US

R. D. (pessoa física)

US

V. O. (pessoa física)

US

Technical data

Priority claims

US

62/863,463 · 06/19/2019

Abstract

ANTICORPOS ANTIMESOTELINA E IMUNOCONJUGADOS DOS MESMOS.Anticorpos anti-mesotelina e conjugados compreendendo tais anticorpos são descritos aqui, bem como o uso de tais conjugados no tratamento de doenças, como câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

09/26/2023

RPI 2751

Arquivamento - Art. 33 da LPI

#11.1

07/11/2023

RPI 2740

Notificação de entrada na fase nacional - PCT

#1.3

03/03/2022

RPI 2669

Alteração de dados cadastrais

#1.1

12/28/2021

RPI 2660

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.